ABCL-134 Phase Ib Open-Label Study of Loncastuximab Tesirine in Combination With Other Anticancer Agents in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (LOTIS-7)

Clinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang S419 - 2023
Brian Hess, Melhem Solh1, Mitul Gandhi2, Ying Wang3, Yajuan Qin3, Pier Luigi Zinzani4, Graham Collins5
1Blood and Marrow Transplant Group of Georgia, Atlanta, GA, USA
2Virginia Cancer Specialists, Fairfax, VA, USA.
3ADC Therapeutics America, Murray Hill, NJ, USA
4Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy.
5Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 23

S419

Thông tin tác giả